Jérémy Jost

Dr. Jérémy Jost

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2019 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
EAEmilie Auditeau
Emilie Auditeau
FCFrancois Chassagne
Francois Chassagne
GBGeneviève Bourdy
Geneviève Bourdy
MBMayoura Bounlu
Mayoura Bounlu
JJJérémy Jost
Jérémy Jost
FBFarid Boumediene
Farid Boumediene

1 July 2016 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Closed access
JJJérémy Jost
Jérémy Jost
CBClaire Bahans
Claire Bahans
MCMarie Courbebaisse
Marie Courbebaisse
TTTu-Anh Tran
Tu-Anh Tran
ALAgnes Linglart
Agnes Linglart
VGVincent Guigonis
Vincent Guigonis
Article published by the Endocrine Society Article published by the Endocrine Society

1 March 2018 in Epilepsy & Behavior
Verified
Journal Article
Closed access
JJJérémy Jost
Jérémy Jost
LMLuz Maria Moyano
Luz Maria Moyano
EAEmilie Auditeau
Emilie Auditeau
FBFarid Boumediene
Farid Boumediene
VRVoa Ratsimbazafy
Voa Ratsimbazafy
PPPierre-Marie Preux
Pierre-Marie Preux

1 April 2018 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
EAEmilie Auditeau
Emilie Auditeau
LMLuz Maria Moyano
Luz Maria Moyano
GBGeneviève Bourdy
Geneviève Bourdy
MNMandy Nizard
Mandy Nizard
JJJérémy Jost
Jérémy Jost
FBFarid Boumediene
Farid Boumediene

3 September 2020 in Epilepsia Open
Verified
Journal Article
Open access
PDF file
NSNoudy Sengxeu
Noudy Sengxeu
HDHanh Dufat
Hanh Dufat
FBFarid Boumediene
Farid Boumediene
SVSomchit Vorachit
Somchit Vorachit
PCPhetvongsinh Chivorakoun
Phetvongsinh Chivorakoun
JJJérémy Jost
Jérémy Jost
Objective: Epilepsy is a chronic condition treatable by cost‐effective antiepileptic drugs (AEDs), but limited access to treatment was documented. The availability and affordability of good quality of AEDs play a significant role in access to good health care. This study aimed to assess the availability, affordability, and quality of long‐term AEDs in Lao PDR.Method: A cross‐sectional study was performed in both public and private drug supply chains in urban and rural areas in Lao PDR. Data on AEDs availability and price were obtained through drug suppliers. Affordability was estimated as the number of day wages the lowest‐paid government employee must work to purchase a monthly treatment. Samples of AEDs were collected, and the quality of AEDs was assessed through Medicine Quality Assessment Reporting Guidelines.Results: Out of 237 outlets visited, only 50 outlets (21.1% [95% CI 16.1‐26.8]) had at least one AED available. The availability was significantly different between urban (24.9%) and rural areas (10.0%), P = .017. Phenobarbital 100 mg was the most available (14.3%); followed by sodium valproate 200 mg (9.7%), phenytoin 100 mg (9.7%), and carbamazepine 200 mg (8.9%). In provincial/district hospitals and health centers, AEDs were provided free of charge. In other healthcare facilities, phenytoin 100 mg and phenobarbital 100 mg showed the best affordability (1.0 and 1.2 day wages, respectively) compared to carbamazepine 200 mg (2.3 days) and other AEDs. No sample was identified as counterfeit, but 15.0% [95% CI 7.1‐26.6] of samples were classified as of poor quality.Significance: We quantified and qualified the various factors contributing to the high treatment gap in Lao PDR, adding to diagnostic issues (not assessed here). Availability remains very low and phenobarbital which is the most available and affordable AED was the worst in terms of quality. A drug policy addressing epilepsy treatment gap would reduce these barriers.

12 June 2018 in Epilepsia
Verified
Journal Article
Closed access
PDF file
JJJérémy Jost
Jérémy Jost
VRVoa Ratsimbazafy
Voa Ratsimbazafy
TNThu Trang Nguyen
Thu Trang Nguyen
TNThuy Linh Nguyen
Thuy Linh Nguyen
HDHanh Dufat
Hanh Dufat
PPPierre‐Marie Preux
Pierre‐Marie Preux